E-LIB Suche - Ergebnisse für: Velazquez, Yovana

1

Phenotypic and Functional Characterization of Posoleucel, a..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Velazquez, Yovana...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S427-S428 , 2024

Link: https://doi.org/10.1016/..

2

Phenotypic and functional characterization of posoleucel, a..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Velazquez, Yovana...
Cytotherapy. , 2024

Link: https://doi.org/10.1016/..

3

Assessment of the Cytolytic Potential of a Multivirus-Targe..:

Koukoulias, Kiriakos ; Papayanni, Penelope G. ; Jones, Julia...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S438 , 2024

Link: https://doi.org/10.1016/..

4

T cell immune profiling of respiratory syncytial virus for ..:

Papayanni, Penelope Georgia ; Koukoulias, Kiriakos ; Kuvalekar, Manik...
British Journal of Haematology. 202 (2023) 4 - p. 874-878 , 2023

Link: https://doi.org/10.1111/..

5

Assessment of the cytolytic potential of a multivirus-targe..:

Koukoulias, Kiriakos ; Papayanni, Penelope G. ; Jones, Julia...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Multi-antigen-targeted T-cell therapy to treat patients wit..:

Hoyos, Valentina ; Vasileiou, Spyridoula ; Kuvalekar, Manik...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211071 , 2022

Link: https://doi.org/10.1177/..

7

Exploring hepatitis B virus as an immunotherapeutic target ..:

Lulla, Suhasini ; Chang, Tsung-Yen ; Vasileiou, Spyridoula...
Journal of Hepatology. 77 (2022) - p. S839 , 2022

Link: https://doi.org/10.1016/..

8

Longitudinal analysis of the evolution of cellular immunity..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Velazquez, Yovana...
Haematologica. 108 (2022) 7 - p. 1934-1939 , 2022

Link: https://doi.org/10.3324/..

9

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALV..:

Vasileiou, Spyridoula ; Hill, LaQuisa ; Kuvalekar, Manik...
Haematologica. 108 (2022) 7 - p. 1840-1850 , 2022

Link: https://doi.org/10.3324/..

10

Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to T..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Workineh, Aster...
Transplantation and Cellular Therapy. 27 (2021) 3 - p. S348-S349 , 2021

Link: https://doi.org/10.1016/..

11

37. Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T Cells ..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Workineh, Aster...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S27-S27 , 2021

Link: https://doi.org/10.1093/..

12

Multi-antigen-targeted T-cell therapy to treat patients wit..:

Hoyos, Valentina ; Vasileiou, Spyridoula ; Kuvalekar, Manik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290161/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Longitudinal analysis of the evolution of cellular immunity..:

Vasileiou, Spyridoula ; Kuvalekar, Manik ; Velazquez, Yovana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316232/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALV..:

Vasileiou, Spyridoula ; Hill, LaQuisa ; Kuvalekar, Manik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316279/. , 2022

Link: http://www.ncbi.nlm.nih...

15

DataSheet_1_Assessment of the cytolytic potential of a mult..:

Kiriakos Koukoulias ; Penelope G. Papayanni ; Julia Jones...
doi:10.3389/fimmu.2023.1299512.s001. , 2023

Link: https://doi.org/10.3389/..